Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
flumazenil (mazicon ) (1 trial)
Cataplexy (Phase 2)
Disorders of Excessive Somnolence (Phase 2)
Idiopathic Hypersomnia (Phase 2)
Narcolepsy (Phase 2)
Trials (1 total)
Trial APIs (1 total)